US Patent Issued to GlaxoSmithKline Intellectual Property (No.3) on Sept. 15 for "Compositions and methods for treatment of hepatitis D virus infection" (Belgian, American, German Inventors)

Posted On: 2026-09-15

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,699, issued on Sept. 15, was assigned to GlaxoSmithKline Intellectual Property (No.3) Ltd. (Stevenage, Great Britain).

"Compositions and methods for treatment of hepatitis D virus infection" was invented by Ronald Cornelis Marie Kalmeijer (Titusville, N.J.), Michael Biermer (Berlin), Oliver Lenz (Sint-Katelijne-Waver, Belgium), Maria Gloria Beumont (Titusville, N.J.), Heather Lynn Davis (Schilde, Belgium) and Thomas Naoki Kakuda (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described are RNA interference (RNAi) agents for treating a Hepatitis D Virus (HDV) infection in a subject in need thereof."

The patent was filed on June 22, 20...

Click here to read full article from source

इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया हमे संपर्क करें.

विशेष

Category

Source

Publication

Location

US Patent Issued to GlaxoSmithKline Intellectual Property (No.3) on Sept. 15 for "Compositions and methods for treatment of hepatitis D virus infection" (Belgian, American, German Inventors)